Rayvolve 7
by Azmed 3 variants
Rayvolve 7 is a basic x-ray clinical assessment support software (FDA Class II; FDA product code QBS, Radiological Computer Assisted Detection/Diagnosis Software For Fracture) made by Azmed, cleared under FDA 510(k) K261378 on 28 Aug 2026 and listed in FDA GUDID since 22 Oct 2026 (UDI-DI 03770018071206), active as of 2 Nov 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number03770018071206 | Date22 Oct 2026 | StatusListed |
| United States | FDA 510(k)SESE | NumberK261378 | Date28 Aug 2026 | StatusActive |
Official records
- AccessGUDID record 03770018071206
- FDA 510(k) database K261378
Across registries
- FDA 510(k) K261378 decided 28 Aug 2026 Active
- FDA GUDID UDI-DI 03770018071206 listed 22 Oct 2026 Listed
Timeline
- Cleared FDA 510(k) K261378
- Listed FDA GUDID 03770018071206
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Rayvolve
- Generic name
- Basic x-ray clinical assessment support software
- Model / reference
- 7
- Primary DI / UDI-DI
- 03770018071206
- 510(k) Number
- FDA product code
- QBS
- GMDN term
- Basic x-ray clinical assessment support software
- Device class
- Class II
- Regulation number
- 892.2090
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code QBS (Radiological Computer Assisted Detection/Diagnosis Software For Fracture).